The Safety of COVID-19 Vaccinations—We Should Rethink the Policy
Update: 5/7/21 the study was "unpublished" from mdpi.com but we have managed to obtain a PDF copy which is linked below.
“Background: COVID-19 vaccines have had expedited reviews without sufficient safety data. We wanted to compare risks and benefits. Method: We calculated the number needed to vaccinate (NNTV) from a large Israeli field study to prevent one death. We accessed the Adverse Drug Reactions (ADR) database of the European Medicines Agency and of the Dutch National Register (lareb.nl) to extract the number of cases reporting severe side effects and the number of cases with fatal side effects. Result: The NNTV is between 200–700 to prevent one case of COVID-19 for the mRNA vaccine marketed by Pfizer, while the NNTV to prevent one death is between 9000 and 50,000 (95% confidence interval), with 16,000 as a point estimate. The number of cases experiencing adverse reactions has been reported to be 700 per 100,000 vaccinations. Currently, we see 16 serious side effects per 100,000 vaccinations, and the number of fatal side effects is at 4.11/100,000 vaccinations. For three deaths prevented by vaccination we have to accept two inflicted by vaccination. Conclusions: This lack of clear benefit should cause governments to rethink their vaccination policy.”
Appearances Can Be Deceiving - Viral-like Inclusions in COVID-19 Negative Renal Biopsies by Electron Microscopy.
“We have observed morphologically indistinguishable inclusions within podocytes and tubular epithelial cells both in patients negative for coronavirus disease 2019 (COVID-19) as well as in renal biopsies from the pre-COVID-19 era”
International Journal of Vaccine Theory, Practice, and Research
Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID-19
Disease Mitigation Measures in the Control of Pandemic Influenza
BIOSECURITY AND BIOTERRORISM: BIODEFENSE STRATEGY, PRACTICE, AND SCIENCE Volume 4, Number 4, 2006
Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity.
NIH National Institutes of Health
Bacterial Pneumonia Caused Most Deaths in 1918 Influenza Pandemic
PubMed Journal - National Library of Medicine
Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease.
"COVID-19 vaccines designed to elicit neutralising antibodies may sensitise vaccine recipients to more severe disease than if they were not vaccinated. Vaccines for SARS, MERS and RSV have never been approved, and the data generated in the development and testing of these vaccines suggest a serious mechanistic concern..."
Department of Pediatrics David Geffen School of Medicine at UCLA
"I am a pediatric specialist caring for children with the multisystem inflammatory syndrome (MIS-C). I am concerned about the possibility that the new vaccines aimed at creating immunity against the SARS-CoV-2 spike protein (including the mRNA vaccines of Moderna and Pfizer) have the potential to cause microvascular injury to the brain, heart, liver, and kidneys in a way that is not currently being assessed in safety trials of these potential drugs."
UK Medical Freedom Alliance
Issues being raised about the inclusion of Polyethylene Glycol (PEG) and its possible relation to anaphylaxis following vaccination.
The Pfizer/BioNTech COVID-19 vaccine contains polyethylene glycol (PEG). As stated in Pfizer/BioNTech’s own “Information for UK recipients”: “This vaccine contains polyethylene glycol/macrogol (PEG) as part of ALC-0159”i . The MHRA’s own Public Assessment report states that the PEG used in the Pfizer vaccine, ALC-0159 (2-[(polyethylene glycol)-2000]-N,Nditetradecylacetamide), is considered novel in that it has “not been used in an authorised medicinal product in the UK” PEG has never been used before in an approved vaccine. The Moderna vaccine also contains PEG in the form of 1,2-dimyristoyl-rac-glycero3- methoxypolyethylene glycol-2000 [PEG2000-DMG]. There is increasing speculation that PEG may be triggering the anaphylaxis. Polyethylene glycols are known to cause IgE-mediated allergic reactions . These hypersensitivity reactions may not be rare; Yang et al (2015) found anti-PEG antibodies in around 42% of healthy adult individuals.
PubMed Journal - National Library of Medicine
Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season
Infectious Diseases Society of America (IDSA)
Correlation Between 3790 Quantitative Polymerase Chain Reaction–Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates
Bulgarian Pathology Association
"COVID19 PCR Tests are Scientifically Meaningless"
British Medical Journal (BMJ)
Jessica C. Watson from Bristol University - paper: “Interpreting a COVID-19 test result”, published in The British Medical Journal, there is a “lack of such a clear-cut ‘gold-standard’ for COVID-19 testing.”
Centers for Disease and Control (CDC)
Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States.
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections, revealing antibodies fall off just 2 to 3 months after infection.
Research Gate - Pakistan Journal of Medical Sciences Online · January 2012
Effect of face veil on ventilator function among Saudi adult females
"Free and unobstructed airflow in the upper and lower respiratory tract during inspiration and expiration is a prerequisite for normal respiratory function. Any pathological or non-pathological condition that can compromise free airflow during respiratory cycle can result in hypoventilation with increased respiratory effort that can lead to physiological burden involving cardiovascular and temperature regulatory system,1 and can also cause psychological stresses".